Continue to perfect your practice on demand
Watch EuroPCR 2025 sponsored scientific sessions to make sure you stay up to date with the 12 177 peers that joined us at the congress.
Replay From Imaging to Intervention - Cutting-Edge Solutions for Calcified Coronary Stenoses Management
CORONARY THERAPIES · CALCIFIED LESIONS · IVUS · LESION PREPARATION
"Fundamentally, optimal outcomes in calcified lesions can only be achieved by this kind of sequential approach to adaptation with appropriate devices, using IVUS, Rotacut techniques, and a hybrid of both stenting and drug-coated balloon."
— Tom Johnson
Session details
Anchorperson: Emanuele Barbato
Spokesperson: Tom Johnson
Discussants: Roberto Diletti, Kalaivani Mahadevan, Beatrice Vaquerizo
Guest Speakers: Javier Escaned, Jan Malte Sinning
Operator: Johannes Rigger
- How to improve procedural success in heavily calcified lesions with the use of several calcium modification tools
- How to leverage IVUS findings to assess calcified coronary lesions and tailor treatment strategies for optimal outcomes
- The applications of drug-eluting therapies in complex calcified lesions
Watch Integration of CT and IVUS for Treatment of Coronary Artery Disease in Daily Practice: From Planning to Drug-Eluting Therapy
CORONARY THERAPIES · CT IMAGING · IVUS · DRUG-ELUTING THERAPIES · IMAGE-GUIDED PCI
"In this case, so we are in the so-called modern PCI, because we started with CT scan, then we have the angiography, then we have the IVUS, and then we are deciding either to go with the drug-coated balloon or drug-eluting stent."
— Salvatore Burgaletta
Session details
Anchorperson: Salvatore Brugaletta
Spokesperson: Marta Kaluzna
Discussants: Johannes Rigger, Maksymilian Opolski
Speakers: Constantin von zur Mühlen, Nicolas Amabile
- The role of CT scan and intravascular imaging in guiding clinical decision-making for the treatment of coronary artery disease
- A step-by-step approach to select appropriate tools and techniques for optimal patients’ outcomes
- How to optimise use of drug-eluting therapies in the treatment of coronary artery disease
Understand the Broadening OPTIONs for LAA Closure: Innovations and Outcomes
LAAC · OPTION TRIAL · WATCHMAN FLX · STROKE PREVENTION · LEFT ATRIAL APPENDAGE CLOSURE
"We now have the option to treat patients who don’t want lifelong anticoagulation — with safety and efficacy."
— Apostolos Tzikas
Session details
Anchorperson: Jens Erik Nielsen-Kudsk
Spokesperson: Carsten Skurk
Discussants: Adel Aminian, Livia Luciana Gheorghe, Lorenz Räber, Apostolos Tzikas
- Clinical data from the OPTION trial and its implications for practice
- How OPTION trial findings could influence clinical decision-making
- Upcoming innovations in the WATCHMAN FLX product pipeline
Discover A Simple Low Profile Solution to the Pulmonary Embolism Problem: EKOS
PULMONARY EMBOLISM · EKOS · ULTRASOUND-ASSISTED THROMBOLYSIS · CLOT RESOLUTION · MINIMALLY INVASIVE THERAPY
"EKOS is capable of providing improvement in right ventricular function and pulmonary perfusion, enables timely reperfusion in appropriately selected patients, delivers low-dose thrombolytic therapy directed to the clot and is a minimally invasive procedure with a low complication rate."
— Jakub Stepniewski
Session details
Anchorperson: Andrew Sharp
Spokesperson: Stavros Konstantinides
Discussants: Robert Ariëns, Jakub Stepniewski
- The effect of ultrasound on clot structure and its benefit for clot dissolution, together with low lytic dosage
- The value of rigorous science and standardized protocols in PE treatment
- How to apply insights from real cases to build your own treatment strategy and take-home examples
Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.